Curran Simpson

Curran Simpson

President and Chief Executive OfficeratRegenxbio· In proxies 2021–2025

Pay in FY2025-12% from the year before · Regenxbio stock +86.3% the same year

Curran Simpson was paid $4.2M in FY2025 (Dec), down 12%. Regenxbio stock rose 86.3% that year.

Pay$100 in the stock at the end of FY20 → $32
Pay is from the Summary Compensation Table of each Regenxbio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. RegenxbioPublic company · 5 yr
    • President and Chief Executive Officer2021 – Present · 5 yrStock in role -85%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?